Key Takeaways: Hysterectomy with bilateral oophorectomy causes an immediate 50%+ drop in testosterone and near-complete loss of ovarian estrogen. Unlike natural menopause, which unfolds over years, surgical menopause happens overnight. Estrogen therapy should start within days of surgery. Testosterone -- often overlooked -- addresses the fatigue, low libido, brain fog, and body composition changes that estrogen alone does not fix. Without a uterus, progesterone is unnecessary, simplifying the protocol.
What Hysterectomy Does to Your Hormones
Hysterectomy is one of the most common surgeries in the United States, with roughly 600,000 performed annually. But the hormonal impact depends entirely on what is removed.
There are three scenarios, and they produce very different outcomes:
Hysterectomy alone (uterus only, ovaries preserved): Hormone production continues because the ovaries remain intact. Some women experience earlier ovarian decline due to disrupted blood supply to the ovaries, but many maintain normal hormone levels for years. HRT may not be immediately needed, though monitoring is important.
Hysterectomy with unilateral oophorectomy (one ovary removed): The remaining ovary typically compensates and maintains adequate hormone production. Monitoring is still recommended, as the single remaining ovary may decline earlier than expected.
Hysterectomy with bilateral oophorectomy (both ovaries removed): This is surgical menopause. Estrogen production drops 80-90% within 24 hours. Testosterone drops approximately 50% immediately, because the ovaries produce roughly half of a woman's circulating testosterone even after natural menopause. This is the scenario that demands immediate and comprehensive HRT.
The Rancho Bernardo Study found that women who had bilateral oophorectomy had 40-50% lower total and bioavailable testosterone compared to women with intact ovaries across all age groups studied.
The Ovaries Are Not Just About Estrogen
This is the point most women -- and many doctors -- miss. The ovaries are not only estrogen factories. They produce meaningful quantities of testosterone throughout a woman's entire life, including well past natural menopause.
Research confirms that the postmenopausal ovary remains a critical source of androgens. Removing both ovaries does not just eliminate estrogen. It eliminates a major source of testosterone and its precursors, including androstenedione and DHEA.
This is why estrogen-only HRT after bilateral oophorectomy leaves many women feeling like something is still missing. The fatigue, the absent libido, the brain fog, the difficulty maintaining muscle -- these are testosterone deficiency symptoms, and estrogen does not address them.
The Surgical Menopause Difference
Natural menopause is a gradual transition. Hormone levels fluctuate and decline over 5-10 years during perimenopause. The body has time to partially adapt.
Surgical menopause is a cliff. One day your ovaries are producing hormones. The next day they are gone. The abruptness of this change is why surgical menopause symptoms tend to be more severe than natural menopause symptoms:
- Hot flashes and night sweats are often more intense and frequent
- Mood disruption can be sudden and severe -- anxiety, depression, irritability
- Sexual function declines sharply, with loss of desire, arousal difficulty, and vaginal dryness occurring simultaneously
- Cognitive symptoms like brain fog and memory difficulty can appear within days
- Sleep disruption compounds every other symptom
- Bone loss begins accelerating immediately without estrogen
The Rocca et al. Mayo Clinic cohort study found that women who underwent bilateral oophorectomy before age 45 had significantly increased cardiovascular mortality and increased risk of cognitive impairment -- unless they received estrogen therapy through at least age 45. The protective effect of timely HRT was clear and substantial.
This data makes a strong case: for premenopausal women undergoing bilateral oophorectomy, HRT is not optional. It is protective.
Which Hormones You Need After Hysterectomy
The answer depends on whether your ovaries were removed. But if they were, the protocol is actually simpler than standard menopausal HRT because you do not need progesterone.
Estrogen: The Foundation
Estrogen replacement is the first priority after bilateral oophorectomy. It addresses the vasomotor symptoms (hot flashes, night sweats), protects bone density, supports cardiovascular health when started early, and improves mood and sleep.
The key advantage of post-hysterectomy HRT: without a uterus, you do not need progesterone. Progesterone's primary role in HRT is preventing estrogen-driven endometrial hyperplasia. No uterus means no endometrium to protect. This eliminates one medication, reduces potential side effects, and simplifies your protocol.
The Women's Health Initiative estrogen-alone trial -- which studied women with prior hysterectomy on conjugated equine estrogen -- found a reduction in hip fracture risk and no increase in coronary heart disease over 6.8 years of follow-up. The risk profile of estrogen alone was substantially better than the estrogen-plus-progestin arm of the trial.
Delivery methods for estrogen:
| Method |
Typical Dose |
Advantages |
Considerations |
| Transdermal patch |
0.025-0.1 mg/day |
Steady levels, bypasses liver, lower clot risk |
Skin irritation possible |
| Topical gel/cream |
0.5-1.5 mg/day |
Easy to adjust dose, good absorption |
Must avoid skin contact with others |
| Oral estradiol |
0.5-2 mg/day |
Convenient, inexpensive |
Increases SHBG, slightly higher clot risk |
| Pellets |
25-75 mg every 3-4 months |
Set and forget, very steady levels |
Requires minor procedure for insertion |
Transdermal delivery (patch, gel, or cream) is generally preferred because it avoids first-pass liver metabolism, does not raise SHBG (which can bind testosterone), and carries lower blood clot risk compared to oral estrogen.
Testosterone: The Missing Piece
This is where most post-hysterectomy HRT protocols fall short. Surgeons prescribe estrogen. Patients feel better -- but not all the way better. The testosterone gap goes unaddressed.
The 2019 Global Consensus Position Statement on testosterone therapy for women identified hypoactive sexual desire disorder (HSDD) in postmenopausal women as the primary evidence-based indication for testosterone therapy. Surgically menopausal women represent the strongest subset of this population, because their testosterone loss is acute, measurable, and directly tied to the surgery.
The clinical evidence is robust. The Davis et al. 2019 Lancet meta-analysis of 36 randomized controlled trials (8,480 participants) found that testosterone therapy significantly improved sexual desire, arousal, orgasm, satisfaction, and reduced sexual distress in postmenopausal women. The effect sizes were clinically meaningful, not just statistically significant.
The ISSWSH Clinical Practice Guideline further supports systemic transdermal testosterone for women with HSDD not primarily caused by relationship or mental health factors. The guideline specifies monitoring to maintain testosterone concentrations within the physiologic premenopausal range.
But testosterone's benefits after hysterectomy extend beyond libido:
- Energy and fatigue: Many women report testosterone as the single biggest factor in recovering their pre-surgical energy levels
- Cognitive function: Improved mental clarity, focus, and word retrieval
- Body composition: Better muscle maintenance and easier fat management
- Mood: Reduced anxiety and improved sense of well-being
- Bone density: Testosterone has independent bone-protective effects alongside estrogen
For detailed dosing by delivery method, see the Women's Testosterone Dosage Guide.
DHEA: The Supporting Role
DHEA (dehydroepiandrosterone) is an adrenal precursor that converts to both testosterone and estrogen in peripheral tissues. After oophorectomy, the adrenal glands become the primary remaining source of androgen precursors.
Some clinicians add low-dose oral DHEA (10-25 mg/day) or intravaginal DHEA (prasterone) for vaginal health. Intravaginal DHEA is FDA-approved for treating vaginal dryness and pain with intercourse in postmenopausal women.
DHEA is not a substitute for direct testosterone replacement, but it can complement it, particularly for vaginal symptoms.
When to Start: The Timing Question
Estrogen: Start Immediately
If ovaries were removed, estrogen should be initiated as soon as possible post-surgery. Many surgeons prescribe estrogen to begin within 24-72 hours. Some start it in the hospital. There is no medical reason to delay.
The "timing hypothesis" from the WHI data supports this: estrogen started close to the onset of menopause (whether natural or surgical) provides the greatest cardiovascular and cognitive benefit. Women who started estrogen within 10 years of menopause had better outcomes than those who waited.
For surgical menopause, the clock starts ticking the moment the ovaries are removed. Early initiation is protective. Delay is not.
Testosterone: Add After Initial Recovery
Testosterone is typically introduced 4-8 weeks after surgery, once the initial surgical recovery is complete and estrogen therapy is stabilized. Some providers introduce testosterone sooner -- there is no strict contraindication, but most prefer to establish the estrogen baseline first and then layer testosterone on top.
Starting testosterone separately from estrogen also makes it easier to attribute symptom changes to the correct hormone and adjust accordingly.
The Worst Option: Waiting
Some women are told to "see how they feel" before starting HRT after oophorectomy. This approach has no evidence behind it and real risks against it. Bone loss begins immediately. Cardiovascular protection is time-dependent. Every week without estrogen after oophorectomy is a week of unmitigated hormonal deficiency.
If your surgeon recommends waiting months before starting HRT after bilateral oophorectomy, seek a second opinion. The evidence consistently supports early initiation.
The Recovery Timeline With HRT
With properly initiated HRT after hysterectomy with oophorectomy, here is what most women can expect:
Week 1-2 (estrogen started):
- Hot flashes begin improving within days
- Sleep quality starts to stabilize
- Mood swings may begin to settle
Week 2-4:
- Vasomotor symptoms significantly reduced
- Energy begins returning
- Surgical recovery progressing alongside hormonal stabilization
Week 4-8 (testosterone added):
- Early improvements in energy and motivation
- Cognitive clarity begins improving
- Still early -- full testosterone effects take longer
Month 2-3:
- Libido begins returning
- Muscle recovery and exercise tolerance improving
- Mood stabilization continuing
- Brain fog clearing
Month 3-6:
- Full testosterone benefits emerging
- Sexual function approaching new baseline
- Body composition changes becoming noticeable
- Most women report feeling "like themselves again"
Month 6-12:
- Optimization phase -- fine-tuning doses based on labs and symptoms
- Long-term benefits consolidating
- Bone density stabilization (measurable by DEXA at 12 months)
This is not a linear process. Some weeks will be better than others. But the trajectory should be consistently upward. If it is not, your doses likely need adjustment.
For a detailed week-by-week breakdown, see Testosterone Before and After: Women's Timeline.
Protocol Specifics
Starting Doses
| Hormone |
Starting Dose |
Target Range |
| Estradiol (transdermal) |
0.05 mg/day patch or equivalent |
Symptom resolution + E2 50-200 pg/mL |
| Testosterone (topical cream) |
2.5-5 mg/day |
Total T 50-70 ng/dL |
| DHEA (optional, oral) |
10-25 mg/day |
DHEA-S in mid-range |
Monitoring Schedule
- Pre-surgery baseline: Total T, free T, estradiol, SHBG, DHEA-S, CBC, metabolic panel (if time allows)
- 6-8 weeks post-op: Estradiol, total T, free T, SHBG, CBC
- 3 months: Comprehensive panel + symptom assessment
- 6 months: Full labs, DEXA bone density scan (optional but recommended baseline)
- Ongoing: Every 6-12 months with a hormone-specialized provider
What to Watch For
Signs testosterone dose is right: Improved energy, returning libido, better mood, cognitive clarity, no androgenic side effects.
Signs testosterone dose is too high: Acne (especially jawline), increased facial hair, oily skin, irritability, clitoral sensitivity. Reduce dose and recheck levels.
Signs testosterone dose is too low: Persistent fatigue despite adequate estrogen, absent libido, continued brain fog, difficulty building or maintaining muscle.
Working with a provider experienced in women's hormone optimization makes this process significantly smoother. Many general practitioners and even gynecologists lack training in testosterone therapy for women. An HRT-specialized clinic will know how to titrate all three axes.
Find a women's HRT clinic that prescribes testosterone alongside estrogen.
Special Situations
Hysterectomy for Cancer
If your hysterectomy was for gynecological cancer, HRT decisions are more nuanced and must involve your oncologist. Estrogen therapy after endometrial cancer is increasingly considered safe (particularly for early-stage disease), but the decision is individualized. Testosterone therapy in this context has limited data but no known contraindication at physiological doses.
Hysterectomy With Ovaries Preserved
If your ovaries were preserved, you may not need immediate HRT. However, research suggests that hysterectomy -- even with ovarian preservation -- can accelerate ovarian decline due to disrupted blood supply. Monitor hormone levels annually. If symptoms of deficiency develop, do not wait.
Young Women (Under 40)
Premature surgical menopause carries the highest long-term risk. The Rocca et al. data shows significantly increased cardiovascular and neurological mortality in women who underwent early oophorectomy without estrogen replacement. HRT should continue at minimum through the natural age of menopause (around 51) and often beyond.
These women typically need higher estrogen doses than older surgical menopause patients, and testosterone is particularly important for maintaining quality of life during what should be their peak years.
Finding the Right Provider
Post-hysterectomy HRT is not difficult -- but it requires a provider who understands all three hormones (estrogen, testosterone, and when relevant, DHEA) and is willing to prescribe testosterone for women.
Many gynecologists will prescribe estrogen after oophorectomy. Far fewer will add testosterone. If your current provider is not comfortable prescribing testosterone, you have two good options:
-
Online HRT clinics that specialize in women's hormone therapy -- these providers prescribe testosterone routinely and understand female-specific dosing. See our comparison of women's HRT clinics.
-
Hormone-specialized providers like those at Peter MD, which offers comprehensive women's HRT including testosterone, estrogen, and progesterone (when needed) through a telehealth model.
The goal is a provider who treats the full hormonal picture, not just the estrogen piece.
Related Reading
References
- Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. (2000). Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. Journal of Clinical Endocrinology & Metabolism, 85(2), 645-651. PMID: 10690870
- Davis SR, et al. (2019). Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. The Lancet Diabetes & Endocrinology, 7(10), 754-766. PMID: 31353194
- Davis SR, Baber R, Panay N, et al. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Sexual Medicine, 16(9), 1331-1337. PMID: 31488288
- Parish SJ, et al. (2021). International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Sexual Medicine, 18(5), 849-867. PMID: 33814355
- Rocca WA, et al. (2009). Increased cardiovascular mortality after early bilateral oophorectomy. Menopause, 16(1), 15-23. PMID: 19034050
- WHI Steering Committee. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 291(14), 1701-1712. PMID: 15082697
- Davison SL, Bell R, Donath S, Montalto JG, Davis SR. (2005). Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology & Metabolism, 90(7), 3847-3853. PMID: 15827095
- Wierman ME, et al. (2014). Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 99(10), 3489-3510. PMID: 25279570
This content is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting any hormone therapy, particularly after surgery. Individual treatment decisions should involve your surgeon and endocrinologist.